Genes overexpressed in AITL compared to PTCL-u
| Gene symbol . | Gene title . | Fold difference of geometric means . |
|---|---|---|
| Cell-to-cell communication | ||
| CD151 | CD151 antigen | 1.35 |
| CD200* | CD200 antigen | 2.38 |
| CD24 | CD24 antigen (small-cell lung carcinoma cluster 4 antigen) | 1.78 |
| CD40LG*† | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | 1.64 |
| CDH11 | Cadherin 11, type 2, OB-cadherin (osteoblast) | 1.7 |
| CDH3 | Cadherin 3, type 1, P-cadherin (placental) | 1.47 |
| CLEC4G | C-type lectin superfamily 4, member G | 2.02 |
| ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 1.42 |
| ITGAX | Integrin, alpha X (antigen CD11C [p150], alpha polypeptide) | 1.89 |
| ITM2C | Integral membrane protein 2C | 2.65 |
| KAL1 | CD82 antigen | 1.48 |
| L1CAM | L1 cell adhesion molecule | 1.56 |
| MAL | Mal, T-cell differentiation protein | 4.62 |
| MME† | Membrane metallopeptidase (neutral endopeptidase, CALLA, CD10) | 2.26 |
| PCDH17 | Protocadherin 17 | 1.66 |
| PCDHA | Protocadherin alpha subfamily | 2.9 |
| PCDHG | Protocadherin gamma subfamily | 1.5 |
| PDCD1*† | Programmed cell death 1 | 1.64 |
| PLEKHC1 | Pleckstrin homology domain containing, family C member 1 | 1.81 |
| Vascular biology | ||
| AMOTL1 | Angiomotin-like 1 | 1.35 |
| ANGPT2 | Angiopoietin 2 | 1.34 |
| EDG2 | Endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 | 2.03 |
| EDG3 | Endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 | 4.05 |
| EFNB2 | Ephrin-B2 | 2.63 |
| ENG | Endoglin (Osler-Rendu-Weber syndrome 1) | 1.56 |
| EPAS1 | Endothelial PAS domain protein 1 | 1.81 |
| EPHA2 | EPH receptor A2 | 1.38 |
| FGF11 | Fibroblast growth factor 11 | 1.65 |
| GAS6 | Growth-arrest specific 6 | 2.04 |
| GJA1 | Gap junction protein, alpha 1, 43 kDa (connexin 43) | 2.18 |
| GJA4 | Gap junction protein, alpha 4, 37 kDa (connexin 37) | 2.08 |
| GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | 1.98 |
| L1CAM | L1 cell adhesion molecule | 1.56 |
| PGF | Placental growth factor, vascular endothelial growth factor-related protein | 1.66 |
| SELP | Selectin P (granule membrane protein 140 kDa, antigen CD62) | 2.42 |
| SERPINF1 | Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin), member 1 | 1.67 |
| SERPINH1 | Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1 | 1.66 |
| THBD | Thrombomodulin | 2.03 |
| THY1 | Thy-1 cell surface antigen | 2.42 |
| VCAM1 | Vascular cell adhesion molecule 1 | 1.76 |
| VEGF | Vascular endothelial growth factor | 1.73 |
| VWA1 | Von Willebrand factor A domain containing 1 | 1.52 |
| Humoral immune response | ||
| C1QTNF1 | C1q and tumor necrosis factor-related protein 1 | 1.8 |
| C1R | Complement component 1, r subcomponent | 1.53 |
| C3 | Complement component 3 | 2.67 |
| CLU | Clusterin | 3.26 |
| CR2 | Complement component (3d/Epstein-Barr virus) receptor 2 | 6.11 |
| FCAMR | Fc receptor, IgA, IgM, high affinity | 4.94 |
| IGH | Immunoglobulin heavy locus | 3.09 |
| IGHM | Immunoglobulin heavy constant mu | 3.82 |
| IGKC† | Immunoglobulin kappa constant | 2.38 |
| IGL | Immunoglobulin lambda locus | 2.03 |
| IGLC2 | Immunoglobulin lambda constant 1 | 2.86 |
| IGLC2 | Immunoglobulin lambda joining 3 | 1.8 |
| IGLV3-25 | Immunoglobulin lambda variable 3-25 | 4.05 |
| IGSF3 | Immunoglobulin superfamily, member 3 | 2.21 |
| SDC1 | Syndecan 1 | 3.23 |
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 2.94 |
| TCF3 | Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 1.65 |
| TNFRSF17 | Tumor necrosis factor receptor superfamily, member 17 | 4.04 |
| Chemokine and cytokine pathways | ||
| CCL19 | Chemokine (C-C motif) ligand 19 (EBV-induced receptor ligand chemokine, ELC) | 1.99 |
| CCL20 | Chemokine (C-C motif) ligand 20 (secondary lymphoid tissue chemokine, SLC) | 4.09 |
| CCL22 | Chemokine (C-C motif) ligand 22 (macrophage-derived chemokine, MDC) | 3.68 |
| CCL24 | Chemokine (C-C motif) ligand 24 (eotaxin-2) | 3 |
| CCL26 | Chemokine (C-C motif) ligand 26 (eotaxin-3) | 5.37 |
| CXCL13*† | Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) | 2.79 |
| CXCL14 | Chemokine (C-X-C motif) ligand 14 (breast and kidney chemokine, BRAK) | 2.17 |
| IL4 | Interleukin 4 | 2.41 |
| LIF† | Leukemia inhibitory factor (cholinergic differentiation factor) | 3.8 |
| OSMR | Receptor to oncostatin M (an IL-6 type cytokine) | 2.22 |
| Extracellular matrix | ||
| ADAM19 | ADAM metallopeptidase domain 19 (meltrin beta) | 2.23 |
| ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 1.65 |
| CHPF | Chondroitin polymerizing factor | 1.47 |
| COL15A1 | Collagen, type XV, alpha 1 | 2.72 |
| COL23A1 | Collagen, type XXIII, alpha 1 | 1.25 |
| COL27A1 | Collagen, type XXVII, alpha 1 | 1.87 |
| COL6A1 | Collagen, type VI, alpha 1 | 2.28 |
| COL6A2 | Collagen, type VI, alpha 2 | 2.27 |
| CTSH | Cathepsin H | 1.72 |
| EFEMP2 | EGF-containing fibulin-like extracellular matrix protein 2 | 1.54 |
| FNDC1 | Fibronectin type III domain containing 1 | 2.27 |
| FOXF1 | Forkhead box F1 | 1.74 |
| HS3ST1 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 1.56 |
| LAD1 | Ladinin 1 | 1.38 |
| LAMB2 | Laminin, beta 2 (laminin S) | 1.66 |
| LAMC2 | Laminin, gamma 2 | 1.63 |
| MMP1 | Matrix metallopeptidase 1 (interstitial collagenase) | 3.72 |
| MMP12 | Matrix metallopeptidase 12 (macrophage elastase) | 5.01 |
| PCOLCE | Procollagen C-endopeptidase enhancer | 1.94 |
| TGFB1/1 | Transforming growth factor beta 1-induced transcript 1 | 1.87 |
| TGFB3 | Transforming growth factor, beta 3 | 1.27 |
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 1.57 |
| VTN | Vitronectin (serum spreading factor, somatomedin B) | 1.49 |
| Others/miscellaneous | ||
| NFATC1*† | Nuclear factor of activated T cells cytoplasmic, calcineurin-dependent 1 | 1.69 |
| PIM2† | Pim-2 oncogene | 1.66 |
| VAV2 | Vav 2 oncogene | 1.82 |
| Gene symbol . | Gene title . | Fold difference of geometric means . |
|---|---|---|
| Cell-to-cell communication | ||
| CD151 | CD151 antigen | 1.35 |
| CD200* | CD200 antigen | 2.38 |
| CD24 | CD24 antigen (small-cell lung carcinoma cluster 4 antigen) | 1.78 |
| CD40LG*† | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | 1.64 |
| CDH11 | Cadherin 11, type 2, OB-cadherin (osteoblast) | 1.7 |
| CDH3 | Cadherin 3, type 1, P-cadherin (placental) | 1.47 |
| CLEC4G | C-type lectin superfamily 4, member G | 2.02 |
| ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 1.42 |
| ITGAX | Integrin, alpha X (antigen CD11C [p150], alpha polypeptide) | 1.89 |
| ITM2C | Integral membrane protein 2C | 2.65 |
| KAL1 | CD82 antigen | 1.48 |
| L1CAM | L1 cell adhesion molecule | 1.56 |
| MAL | Mal, T-cell differentiation protein | 4.62 |
| MME† | Membrane metallopeptidase (neutral endopeptidase, CALLA, CD10) | 2.26 |
| PCDH17 | Protocadherin 17 | 1.66 |
| PCDHA | Protocadherin alpha subfamily | 2.9 |
| PCDHG | Protocadherin gamma subfamily | 1.5 |
| PDCD1*† | Programmed cell death 1 | 1.64 |
| PLEKHC1 | Pleckstrin homology domain containing, family C member 1 | 1.81 |
| Vascular biology | ||
| AMOTL1 | Angiomotin-like 1 | 1.35 |
| ANGPT2 | Angiopoietin 2 | 1.34 |
| EDG2 | Endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 | 2.03 |
| EDG3 | Endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 | 4.05 |
| EFNB2 | Ephrin-B2 | 2.63 |
| ENG | Endoglin (Osler-Rendu-Weber syndrome 1) | 1.56 |
| EPAS1 | Endothelial PAS domain protein 1 | 1.81 |
| EPHA2 | EPH receptor A2 | 1.38 |
| FGF11 | Fibroblast growth factor 11 | 1.65 |
| GAS6 | Growth-arrest specific 6 | 2.04 |
| GJA1 | Gap junction protein, alpha 1, 43 kDa (connexin 43) | 2.18 |
| GJA4 | Gap junction protein, alpha 4, 37 kDa (connexin 37) | 2.08 |
| GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | 1.98 |
| L1CAM | L1 cell adhesion molecule | 1.56 |
| PGF | Placental growth factor, vascular endothelial growth factor-related protein | 1.66 |
| SELP | Selectin P (granule membrane protein 140 kDa, antigen CD62) | 2.42 |
| SERPINF1 | Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin), member 1 | 1.67 |
| SERPINH1 | Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1 | 1.66 |
| THBD | Thrombomodulin | 2.03 |
| THY1 | Thy-1 cell surface antigen | 2.42 |
| VCAM1 | Vascular cell adhesion molecule 1 | 1.76 |
| VEGF | Vascular endothelial growth factor | 1.73 |
| VWA1 | Von Willebrand factor A domain containing 1 | 1.52 |
| Humoral immune response | ||
| C1QTNF1 | C1q and tumor necrosis factor-related protein 1 | 1.8 |
| C1R | Complement component 1, r subcomponent | 1.53 |
| C3 | Complement component 3 | 2.67 |
| CLU | Clusterin | 3.26 |
| CR2 | Complement component (3d/Epstein-Barr virus) receptor 2 | 6.11 |
| FCAMR | Fc receptor, IgA, IgM, high affinity | 4.94 |
| IGH | Immunoglobulin heavy locus | 3.09 |
| IGHM | Immunoglobulin heavy constant mu | 3.82 |
| IGKC† | Immunoglobulin kappa constant | 2.38 |
| IGL | Immunoglobulin lambda locus | 2.03 |
| IGLC2 | Immunoglobulin lambda constant 1 | 2.86 |
| IGLC2 | Immunoglobulin lambda joining 3 | 1.8 |
| IGLV3-25 | Immunoglobulin lambda variable 3-25 | 4.05 |
| IGSF3 | Immunoglobulin superfamily, member 3 | 2.21 |
| SDC1 | Syndecan 1 | 3.23 |
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 2.94 |
| TCF3 | Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 1.65 |
| TNFRSF17 | Tumor necrosis factor receptor superfamily, member 17 | 4.04 |
| Chemokine and cytokine pathways | ||
| CCL19 | Chemokine (C-C motif) ligand 19 (EBV-induced receptor ligand chemokine, ELC) | 1.99 |
| CCL20 | Chemokine (C-C motif) ligand 20 (secondary lymphoid tissue chemokine, SLC) | 4.09 |
| CCL22 | Chemokine (C-C motif) ligand 22 (macrophage-derived chemokine, MDC) | 3.68 |
| CCL24 | Chemokine (C-C motif) ligand 24 (eotaxin-2) | 3 |
| CCL26 | Chemokine (C-C motif) ligand 26 (eotaxin-3) | 5.37 |
| CXCL13*† | Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) | 2.79 |
| CXCL14 | Chemokine (C-X-C motif) ligand 14 (breast and kidney chemokine, BRAK) | 2.17 |
| IL4 | Interleukin 4 | 2.41 |
| LIF† | Leukemia inhibitory factor (cholinergic differentiation factor) | 3.8 |
| OSMR | Receptor to oncostatin M (an IL-6 type cytokine) | 2.22 |
| Extracellular matrix | ||
| ADAM19 | ADAM metallopeptidase domain 19 (meltrin beta) | 2.23 |
| ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 1.65 |
| CHPF | Chondroitin polymerizing factor | 1.47 |
| COL15A1 | Collagen, type XV, alpha 1 | 2.72 |
| COL23A1 | Collagen, type XXIII, alpha 1 | 1.25 |
| COL27A1 | Collagen, type XXVII, alpha 1 | 1.87 |
| COL6A1 | Collagen, type VI, alpha 1 | 2.28 |
| COL6A2 | Collagen, type VI, alpha 2 | 2.27 |
| CTSH | Cathepsin H | 1.72 |
| EFEMP2 | EGF-containing fibulin-like extracellular matrix protein 2 | 1.54 |
| FNDC1 | Fibronectin type III domain containing 1 | 2.27 |
| FOXF1 | Forkhead box F1 | 1.74 |
| HS3ST1 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 1.56 |
| LAD1 | Ladinin 1 | 1.38 |
| LAMB2 | Laminin, beta 2 (laminin S) | 1.66 |
| LAMC2 | Laminin, gamma 2 | 1.63 |
| MMP1 | Matrix metallopeptidase 1 (interstitial collagenase) | 3.72 |
| MMP12 | Matrix metallopeptidase 12 (macrophage elastase) | 5.01 |
| PCOLCE | Procollagen C-endopeptidase enhancer | 1.94 |
| TGFB1/1 | Transforming growth factor beta 1-induced transcript 1 | 1.87 |
| TGFB3 | Transforming growth factor, beta 3 | 1.27 |
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 1.57 |
| VTN | Vitronectin (serum spreading factor, somatomedin B) | 1.49 |
| Others/miscellaneous | ||
| NFATC1*† | Nuclear factor of activated T cells cytoplasmic, calcineurin-dependent 1 | 1.69 |
| PIM2† | Pim-2 oncogene | 1.66 |
| VAV2 | Vav 2 oncogene | 1.82 |